Reshape Biotech is building the next generation of lab automation robots. Our customers are biotech companies tackling the world’s biggest problems - be it alternative protein development or sustainable agriculture. Reshape Biotech is the scaling factor for these companies, as we let researchers collaborate globally on experiments and increase their throughput >500x.
The team is highly multi-disciplinary, employing everything from PhD’s in biology to hardware and software engineers. We work closely together, and you will be exposed to a truly vertical team.
We’re a fast growing startup with an incredibly ambitious team, dead-set on reinventing a 100 year old industry and becoming the standard infrastructure that the world of biotech relies on. Our customers already include global leaders in food, agriculture and biologicals.
We’re backed by top tier investors from Y Combinator, CEOs from the industry and some of the biggest names you can find. At Reshape Biotech, you have the potential to influence how biotech research is done in the next 100 years.
Company Details
- Employees
- 70
- Founded
- -
- Address
- Østbanegade 55, 1.,denmark
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- reshapebiotech.com
- Keywords
- Microbiology automation, Digitalization, Research automation, Biotechnology, Quality control, R&D, Data collection.
- HQ
- Copenhagen, Capital Region of Denmark
Reshape Biotech Questions
Reshape Biotech's website is reshapebiotech.com
Reshape Biotech's LinkedIn profile is https://dk.linkedin.com/company/reshape-biotech
Reshape Biotech has
70 employees.
View email and phone details for 70
employees at Reshape Biotech.
Reshape Biotech's industry is
Biotechnology Research
Reshape Biotech's top competitors are
Nūmi®,
Nordberg Medical,
Artica Therapeutics,
Eyebio,
Delta Life Science,
Biow,
Novonesis,
Cellclar Cic,
Orakl Oncology,
Amber Therapeutics.
Reshape Biotech's categories are Biotechnology Research
Reshape Biotech's founding year is 2018
